% | $
Quotes you view appear here for quick access.

Synta Pharmaceuticals Corp. Message Board

  • snt951 snt951 Apr 7, 2014 9:17 PM Flag

    Pfizer Breast Cancer drug

    Interesting development with Pfizers Breast cancer drug; it appears to be more of a disappointment than good news based on the stock's reaction. Could it lead to possible interest in Synta Breast cancer drug down the road....anything is possible.

    Pfizer Inc (PFE), down 3 percent to $31.20, added pressure to the Dow and S&P 500. The company's experimental breast cancer drug in a clinical trial nearly doubled the amount of time patients lived without their disease getting worse, but overall survival was not yet shown to be statistically significant, researchers said.

0.4279-0.0220(-4.89%)Nov 30 4:00 PMEST